Given the intense focus on the development of COVID-19 vaccines, clinical trials emerged at the forefront of the national conversation. This also brought increased interest in “Decentralized Clinical…

Health and healthcare disparities are driven by complex and interlocking factors within and beyond systems of care. In the wake of COVID-19, the new and long-standing disparities in…

By virtue of sheer volume, oncology trials can set the stage for overall clinical trial innovation. Moreover, oncology as a therapeutic area has seen the closest interplay between…

Life science companies invest billions of dollars each year researching and developing new treatments for patients. Each of these clinical studies is carefully designed to test specific hypotheses…

Each year, pharmaceutical companies spend billions on the generation and procurement of data. But despite investing heavily in data, pharma companies are limited by the basic problem of…

As the healthcare industry moves towards a value-based care model, life sciences companies need to utilize real-world evidence to justify the cost and improve understanding of the effectiveness…

Recently, a biopharmaceutical company completed at 36 week Phase IV study of 175 patients across 40 trial sites to evaluate the effectiveness and safety of a recently approved…

A pharma client partnered with an Advanced Analytics company to develop a model to identify patients likely to have hereditary ATTR amyloidosis.